-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026

路透·08/13/2026 11:27:17

登錄查看新聞詳情